ZA936260B - Novel antibodies for conferring passive immunity against infection by a pathogen in man - Google Patents

Novel antibodies for conferring passive immunity against infection by a pathogen in man

Info

Publication number
ZA936260B
ZA936260B ZA936260A ZA936260A ZA936260B ZA 936260 B ZA936260 B ZA 936260B ZA 936260 A ZA936260 A ZA 936260A ZA 936260 A ZA936260 A ZA 936260A ZA 936260 B ZA936260 B ZA 936260B
Authority
ZA
South Africa
Prior art keywords
pathogen
man
immunity against
against infection
passive immunity
Prior art date
Application number
ZA936260A
Inventor
Mitchell Stuart Gross
Martin Rosenberg
Mark Hurle
Jerald Charles Sadoff
Steven Hoffman
Daniel R Sylvester
Yupin Charoenvit
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA936260B publication Critical patent/ZA936260B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA936260A 1992-09-09 1993-08-26 Novel antibodies for conferring passive immunity against infection by a pathogen in man ZA936260B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94165492A 1992-09-09 1992-09-09

Publications (1)

Publication Number Publication Date
ZA936260B true ZA936260B (en) 1994-03-18

Family

ID=25476840

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936260A ZA936260B (en) 1992-09-09 1993-08-26 Novel antibodies for conferring passive immunity against infection by a pathogen in man

Country Status (9)

Country Link
EP (1) EP0659192A4 (en)
JP (1) JPH08500979A (en)
KR (1) KR950703573A (en)
CN (1) CN1087681A (en)
AU (1) AU4851193A (en)
CA (1) CA2143417A1 (en)
NZ (1) NZ256232A (en)
WO (1) WO1994005690A1 (en)
ZA (1) ZA936260B (en)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782626A1 (en) * 1994-09-19 1997-07-09 Rijkslandbouwuniversiteit Wageningen Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogens in crops
SE9500148D0 (en) * 1995-01-18 1995-01-18 Bioinvent Internatioal Ab Antibodies for use in cancer therapy and diagnosis
AUPP221098A0 (en) 1998-03-06 1998-04-02 Diatech Pty Ltd V-like domain binding molecules
EP0953639A1 (en) * 1998-04-30 1999-11-03 Boehringer Ingelheim International GmbH FAPalpha-specific antibody with improved producibility
US6455677B1 (en) 1998-04-30 2002-09-24 Boehringer Ingelheim International Gmbh FAPα-specific antibody with improved producibility
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
EP2706116A1 (en) * 2001-01-17 2014-03-12 Emergent Product Development Seattle, LLC Binding domain-immunoglobulin fusion proteins
US20030133939A1 (en) 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
AU2008200400B2 (en) * 2001-01-17 2012-06-07 Aptevo Research And Development Llc Binding domain-immunoglobulin fusion proteins
ATE524195T1 (en) * 2001-01-26 2011-09-15 Inhibitex Inc MONOCLONAL ANTIBODIES AGAINST CLFA PROTEIN AND METHOD FOR USE IN THE TREATMENT OR PREVENTION OF INFECTIONS
US8597911B2 (en) 2003-06-11 2013-12-03 Chugai Seiyaku Kabushiki Kaisha Process for producing antibodies
US7754209B2 (en) 2003-07-26 2010-07-13 Trubion Pharmaceuticals Binding constructs and methods for use thereof
TW200530269A (en) 2003-12-12 2005-09-16 Chugai Pharmaceutical Co Ltd Anti-Mpl antibodies
JP5057967B2 (en) 2005-03-31 2012-10-24 中外製薬株式会社 sc (Fv) 2 structural isomer
WO2006106905A1 (en) 2005-03-31 2006-10-12 Chugai Seiyaku Kabushiki Kaisha Process for production of polypeptide by regulation of assembly
CN101262885B (en) 2005-06-10 2015-04-01 中外制药株式会社 Pharmaceutical compositions containing sc(Fv)2
CA2610987C (en) 2005-06-10 2013-09-10 Chugai Seiyaku Kabushiki Kaisha Stabilizer for protein preparation comprising meglumine and use thereof
NI200800032A (en) 2005-07-25 2009-03-23 REDUCTION OF CELL B USING SPECIFIC JOINT MOLECULES CD37 AND CD20
DK2009101T3 (en) 2006-03-31 2018-01-15 Chugai Pharmaceutical Co Ltd Antibody modification method for purification of a bispecific antibody
US11046784B2 (en) 2006-03-31 2021-06-29 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
MX2008015524A (en) 2006-06-12 2009-01-13 Trubion Pharmaceuticals Inc Single-chain multivalent binding proteins with effector function.
SI2202245T1 (en) 2007-09-26 2016-10-28 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substitution in cdr
MY163473A (en) 2007-09-26 2017-09-15 Chugai Pharmaceutical Co Ltd Modified antibody constant region
SI2132228T1 (en) 2008-04-11 2011-10-28 Emergent Product Dev Seatle Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
WO2010107110A1 (en) 2009-03-19 2010-09-23 中外製薬株式会社 Antibody constant region variant
JP5787446B2 (en) 2009-03-19 2015-09-30 中外製薬株式会社 Antibody constant region variants
WO2011026242A1 (en) * 2009-09-03 2011-03-10 Vancouver Biotech Ltd. Monoclonal antibodies against gonadotropin-releasing hormone receptor
US10150808B2 (en) 2009-09-24 2018-12-11 Chugai Seiyaku Kabushiki Kaisha Modified antibody constant regions
EP2543730B1 (en) 2010-03-04 2018-10-31 Chugai Seiyaku Kabushiki Kaisha Antibody constant region variant
CN105859889B (en) 2010-11-17 2020-01-07 中外制药株式会社 Multispecific antigen-binding molecules having a function replacing the function of factor VIII
BR112014010257A2 (en) 2011-10-31 2017-04-18 Chugai Pharmaceutical Co Ltd antigen binding molecule having regulated conjugation between heavy and light chains
US10414820B2 (en) * 2013-03-13 2019-09-17 Imaginab, Inc. Antigen binding constructs to CD8
BR112016006197B1 (en) 2013-09-27 2023-04-11 Chugai Seiyaku Kabushiki Kaisha METHOD FOR PRODUCING A BISPECIFIC POLYPEPTIDE ANTIBODY
FR3025517B1 (en) 2014-09-10 2016-12-23 Repropharm LIGANDS POTENTIATING THE BIOACTIVITY OF GONADOTROPHINS
MA40764A (en) 2014-09-26 2017-08-01 Chugai Pharmaceutical Co Ltd THERAPEUTIC AGENT INDUCING CYTOTOXICITY
WO2016159213A1 (en) 2015-04-01 2016-10-06 中外製薬株式会社 Method for producing polypeptide hetero-oligomer
KR20180050321A (en) 2015-08-07 2018-05-14 이미지냅 인코포레이티드 An antigen binding construct for targeting a molecule
WO2017053469A2 (en) 2015-09-21 2017-03-30 Aptevo Research And Development Llc Cd3 binding polypeptides
EP3398965A4 (en) 2015-12-28 2019-09-18 Chugai Seiyaku Kabushiki Kaisha Method for promoting efficiency of purification of fc region-containing polypeptide
EP3431102A4 (en) 2016-03-14 2019-09-25 Chugai Seiyaku Kabushiki Kaisha Cell injury inducing therapeutic drug for use in cancer therapy
US11266745B2 (en) 2017-02-08 2022-03-08 Imaginab, Inc. Extension sequences for diabodies
CN117854601B (en) * 2024-03-04 2024-05-14 鲁东大学 Decisive complementary region dividing method based on gene type and amino acid sequence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632909A (en) * 1983-10-31 1986-12-30 The United States Of America As Represented By The Department Of Health And Human Services Monoclonal antibodies which block infectivity of malarial parasites to mosquitoes
JPS63267295A (en) * 1986-12-03 1988-11-04 Sumitomo Chem Co Ltd Human antibody, antibody gene and corresponding recombinant

Also Published As

Publication number Publication date
KR950703573A (en) 1995-09-20
EP0659192A4 (en) 1996-09-11
NZ256232A (en) 1997-02-24
CN1087681A (en) 1994-06-08
EP0659192A1 (en) 1995-06-28
AU4851193A (en) 1994-03-29
CA2143417A1 (en) 1994-03-17
WO1994005690A1 (en) 1994-03-17
JPH08500979A (en) 1996-02-06

Similar Documents

Publication Publication Date Title
ZA936260B (en) Novel antibodies for conferring passive immunity against infection by a pathogen in man
EP0497471A3 (en) A technique for improving esd immunity
TW301244U (en) System for improving the fit of a hand in a glove
GB2265221B (en) Inductive sensors
HU9500417D0 (en) Hepatitis a vaccine
HU9300010D0 (en) Glycoprotein vaccine named ehv-4
GB9110698D0 (en) Inductive displacement sensors
AU113431S (en) A bottle
GB9205257D0 (en) A lifting device
GB9206203D0 (en) Inductive sensors
AU111329S (en) A bottle
AU112350S (en) A Bottle
EP0465815A3 (en) Method to palletize textile packages
GB9211116D0 (en) Inductive sensor
GB9026694D0 (en) A damping device
GB9025142D0 (en) Intelligent vibration sensor
GB2296977B (en) Semi-conductor acceleration sensor
KR950022557U (en) Bag shoulder
IL127163A0 (en) A vaccine which provides protective immunity against a bacterial pathogen
CS524390A3 (en) Optoelectronic tactile sensor
BR7201652U (en) handle adaptable to different packaging
GB9108566D0 (en) A responsive robotic technique
KR960000482U (en) Chiropractor that can serve as a gripper
AU109868S (en) A bottle
AU109869S (en) A bottle